Translational Studies on Anti-Atrial Fibrillatory Action of Oseltamivir by its in vivo and in vitro Electropharmacological Analyses

Oseltamivir has been shown to prolong the atrial conduction time and effective refractory period, and to suppress the onset of burst pacing-induced atrial fibrillation in vitro. To better predict its potential clinical benefit as an anti-atrial fibrillatory drug, we performed translational studies b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Kambayashi, Ryuichi, Izumi-Nakaseko, Hiroko, Goto, Ai, Tsurudome, Kazuya, Ohshiro, Hironori, Izumi, Taku, Hagiwara-Nagasawa, Mihoko, Chiba, Koki, Nishiyama, Ryota, Oyama, Satomi, Nunoi, Yoshio, Takei, Yoshinori, Matsumoto, Akio, Sugiyama, Atsushi
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8118603/
https://ncbi.nlm.nih.gov/pubmed/33995006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.593021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados